Positive Physicians Holdings, Inc.

As of June 30, 2022, Positive Physicians Holdings, Inc. carries a market capitalization of 31.35M, placing it among publicly traded companies globally. Its enterprise value stands at -76.83M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2022, Positive Physicians Holdings, Inc. has 3.62M shares outstanding.

These figures are as of June 30, 2022. The price-to-sales ratio is 1.40, and the price-to-book ratio stands at 0.52.

These figures are as of June 30, 2022.

Over the twelve months ended June 30, 2022, Positive Physicians Holdings, Inc. posted a negative return on equity (ROE) of -3.08, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.31, reflecting losses generated across the asset base. The company generates approximately 1.22M in revenue per employee across its workforce of 18.25, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2022, Positive Physicians Holdings, Inc. recorded an income tax benefit of -553,695.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -2.61M and -2.06M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on July 29, 2026, Positive Physicians Holdings, Inc.'s stock has gained approximately 15.38% over the past 52 weeks.

Over the twelve months ended June 30, 2022, Positive Physicians Holdings, Inc. generated 22.34M in revenue and converted that into -2.06M in net income, yielding earnings per share of -0.57.

As of June 30, 2022, Positive Physicians Holdings, Inc. holds 111.47M in cash and equivalents against 3.29M in total debt, resulting in a net debt position of -10.78M.

Positive Physicians Holdings, Inc. produced -1.04M in operating cash flow over the twelve months ended June 30, 2022.

These figures cover the twelve months ended June 30, 2022.

These figures cover the twelve months ended June 30, 2022. Free cash flow yield is negative at -3.30: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.